Nationwide Fund Advisors increased its holdings in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 18.4% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 65,364 shares of the medical instruments supplier’s stock after purchasing an additional 10,158 shares during the period. Nationwide Fund Advisors owned approximately 0.33% of ICU Medical worth $11,275,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also modified their holdings of the stock. Teachers Advisors LLC raised its holdings in shares of ICU Medical by 0.9% during the second quarter. Teachers Advisors LLC now owns 131,611 shares of the medical instruments supplier’s stock worth $22,703,000 after purchasing an additional 1,163 shares during the last quarter. Fiera Capital Corp purchased a new position in shares of ICU Medical during the second quarter worth $36,962,000. Riverhead Capital Management LLC raised its holdings in shares of ICU Medical by 99.8% during the second quarter. Riverhead Capital Management LLC now owns 999 shares of the medical instruments supplier’s stock worth $172,000 after purchasing an additional 499 shares during the last quarter. Martingale Asset Management L P raised its holdings in shares of ICU Medical by 0.3% during the second quarter. Martingale Asset Management L P now owns 38,703 shares of the medical instruments supplier’s stock worth $6,677,000 after purchasing an additional 100 shares during the last quarter. Finally, Wells Fargo & Company MN raised its holdings in shares of ICU Medical by 19.3% during the second quarter. Wells Fargo & Company MN now owns 555,712 shares of the medical instruments supplier’s stock worth $95,861,000 after purchasing an additional 89,872 shares during the last quarter. 78.13% of the stock is owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY NOTICE: This piece was posted by Daily Political and is the sole property of of Daily Political. If you are viewing this piece on another domain, it was illegally copied and reposted in violation of international trademark and copyright laws. The original version of this piece can be viewed at https://www.dailypolitical.com/2017/09/25/nationwide-fund-advisors-acquires-10158-shares-of-icu-medical-inc-icui.html.

In other ICU Medical news, CEO Vivek Jain sold 69,014 shares of the company’s stock in a transaction on Friday, July 7th. The shares were sold at an average price of $171.10, for a total transaction of $11,808,295.40. Following the completion of the transaction, the chief executive officer now owns 110,925 shares in the company, valued at approximately $18,979,267.50. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Robert S. Swinney sold 463 shares of the company’s stock in a transaction on Friday, September 15th. The stock was sold at an average price of $181.25, for a total transaction of $83,918.75. Following the transaction, the director now owns 14,330 shares of the company’s stock, valued at approximately $2,597,312.50. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 213,012 shares of company stock valued at $36,438,659. 15.90% of the stock is owned by insiders.

Several analysts recently commented on ICUI shares. BidaskClub upgraded shares of ICU Medical from a “hold” rating to a “buy” rating in a research report on Saturday, June 17th. Sidoti lowered shares of ICU Medical from a “buy” rating to a “neutral” rating in a research report on Tuesday, June 20th. Zacks Investment Research upgraded shares of ICU Medical from a “hold” rating to a “strong-buy” rating and set a $195.00 price target on the stock in a research report on Wednesday, July 12th. Finally, Gabelli restated a “buy” rating on shares of ICU Medical in a research report on Friday, August 11th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and one has given a buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $193.00.

Shares of ICU Medical, Inc. (NASDAQ:ICUI) opened at 184.90 on Monday. ICU Medical, Inc. has a 52-week low of $124.09 and a 52-week high of $186.25. The company’s 50-day moving average is $173.09 and its 200 day moving average is $164.39. The firm has a market cap of $3.66 billion, a price-to-earnings ratio of 74.05 and a beta of 0.36.

ICU Medical (NASDAQ:ICUI) last announced its quarterly earnings data on Wednesday, August 9th. The medical instruments supplier reported $0.52 EPS for the quarter, missing the Zacks’ consensus estimate of $0.58 by ($0.06). The firm had revenue of $331.51 million for the quarter, compared to analysts’ expectations of $318.30 million. ICU Medical had a return on equity of 7.56% and a net margin of 6.10%. The firm’s quarterly revenue was up 242.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.15 EPS. On average, analysts expect that ICU Medical, Inc. will post $4.11 earnings per share for the current fiscal year.

ICU Medical Profile

ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.